Noticias de Eulerpool Stoke Therapeutics

Stoke Therapeutics Eulerpool-AFX

Stoke Therapeutics Noticias de Acciones

Stoke Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Stoke Therapeutics.

• 23 de septiembre ·

  GuruFocus
  Skorpios Trust Reduces Stake in Stoke Therapeutics Inc
• 13 de septiembre ·

  GuruFocus
  Redmile Group, LLC Expands Stake in Atara Biotherapeutics Inc
• 10 de septiembre ·

  Yahoo
  Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modification in Dravet Syndrome
• 10 de septiembre ·

  Thefly.com
  Stoke Therapeutics presents Zorevunersen data at EEC
• 7 de septiembre ·

  SeekingAlpha
  Stoke Therapeutics: The First Gene Therapy For Dravet Syndrome
• 4 de septiembre ·

  Yahoo
  Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer
• 4 de septiembre ·

  Thefly.com
  Stoke Therapeutics appoints Eric Olson Chief Business Officer.
• 3 de septiembre ·

  Yahoo
  Stoke Therapeutics to Present at Upcoming Investor Conferences in September
• 16 de agosto ·

  Yahoo
  Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• 9 de agosto ·

  Stock Options Channel
  Commit To Purchase Stoke Therapeutics At $12.50, Earn 27.6% Annualized Using Options